Unified Patent Court (UPC) analytics are now available. Check here

EP3027174

AIZANT DRUG RESEARCH SOLUTIONS PRIVATE
Application Number
EP13826764A
Filing Date
Dec 10, 2013
Status
Revoked
Sep 10, 2021
Grant Date
Jul 24, 2019
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP3027174B1 was granted on Jul 24, 2019 by Aizant Drug Research Solutions Private The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBApr 24, 2020ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2004089341
N/A
OppositionWO2010055028
N/A
OppositionGB2400318
N/A
OppositionWO2012135561
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.